PTPRC and neoplasm: Quantitative analysis of multiple tumor tissues showed that over 60% of CD45+ cells were CD11b+/Ly6G+ MDSCs in the tumors of the control group, whereas the MDSCs decrease to less than 20% in the SQLE-KD group (Figure 1D, lower panel).